indican has been researched along with Sarcopenia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 6 (54.55) | 2.80 |
| Authors | Studies |
|---|---|
| Hosoda, Y; Miyazaki, M; Mori, T; Sato, E; Sato, H; Sekimoto, A; Takahashi, N; Todoriki, S; Watanabe, M; Yamamoto, T | 1 |
| An, WS; Cha, RH; Han, MY; Kang, SH; Kim, JC; Kim, SH; Lee, SM | 1 |
| Hasegawa, M; Hori, H; Nakai, S; Nakatani, M; Ohashi, A; Tsuboi, N; Tsuchida, K | 1 |
| Enoki, Y; Maruyama, T; Watanabe, H | 1 |
| Armelloni, S; Caldiroli, L; Cesari, M; Eskander, A; Margiotta, E; Messa, P; Rizzo, V; Vettoretti, S | 1 |
| Higashihara, T; Inagi, R; Maruyama, T; Nangaku, M; Nishi, H; Takemura, K; Tanaka, T; Watanabe, H | 1 |
| Armelloni, S; Caldiroli, L; Callegari, ML; Margiotta, E; Messa, P; Miragoli, F; Rizzo, V; Vettoretti, S; Zanoni, F | 1 |
| Arake, R; Enoki, Y; Fujimura, R; Fukagawa, M; Imafuku, T; Ishima, Y; Ishiodori, K; Komaba, H; Maruyama, T; Matsushita, K; Miyamura, S; Nagao, S; Nishida, K; Otagiri, M; Sugimoto, R; Tanaka, M; Watanabe, H | 1 |
| Ao, UI; Chan, DC; Chen, YS; Chiang, CK; Huang, JW; Hung, KY; Jheng, JR; Tarng, DC | 1 |
| Arake, R; Enoki, Y; Fukagawa, M; Imafuku, T; Ishima, Y; Kotani, S; Maruyama, T; Matsushita, K; Nakajima, M; Otagiri, M; Sugimoto, R; Tanaka, M; Tominaga, Y; Watanabe, H | 1 |
| Abe, T; Ito, S; Kisu, K; Koizumi, K; Kudo, T; Kurasawa, N; Mishima, E; Miura, D; Mokudai, T; Mori, T; Morikawa-Ichinose, T; Naganuma, E; Niwa, T; Niwano, Y; Oba-Yabana, I; Oe, Y; Saigusa, D; Saito, R; Sato, E; Sato, H; Sugawara, S; Suzuki, A; Suzuki, C; Takahashi, N | 1 |
1 review(s) available for indican and Sarcopenia
| Article | Year |
|---|---|
Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions.
Topics: Cytokines; Humans; Indican; Muscle Proteins; Muscle, Skeletal; Myostatin; Oxidative Stress; Proteolysis; Reactive Oxygen Species; Renal Insufficiency, Chronic; Sarcopenia | 2019 |
10 other study(ies) available for indican and Sarcopenia
| Article | Year |
|---|---|
Methylglyoxal Induces Inflammation, Metabolic Modulation and Oxidative Stress in Myoblast Cells.
Topics: Adenosine Triphosphate; Animals; Female; Humans; Indican; Inflammation; Male; Mice; Muscular Atrophy; Myoblasts; Oxidative Stress; Pyruvaldehyde; Renal Insufficiency, Chronic; Sarcopenia | 2022 |
Indoxyl Sulfate Might Play a Role in Sarcopenia, While Myostatin Is an Indicator of Muscle Mass in Patients with Chronic Kidney Disease: Analysis from the RECOVERY Study.
Topics: Hand Strength; Humans; Indican; Muscle, Skeletal; Myostatin; Renal Insufficiency, Chronic; Sarcopenia | 2022 |
Effects of N-acetyl-L-tryptophan on desorption of the protein-bound uremic toxin indoxyl sulfate and effects on uremic sarcopenia.
Topics: Humans; Indican; Sarcopenia; Tryptophan; Uremia; Uremic Toxins | 2023 |
Association between the uremic toxins indoxyl-sulfate and p-cresyl-sulfate with sarcopenia and malnutrition in elderly patients with advanced chronic kidney disease.
Topics: Aged; Cresols; Humans; Indican; Indoles; Malnutrition; Renal Insufficiency, Chronic; Sarcopenia; Sulfates | 2021 |
β2-adrenergic receptor agonist counteracts skeletal muscle atrophy and oxidative stress in uremic mice.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Ascorbic Acid; Cell Size; Clenbuterol; Female; Indican; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitochondria; Muscle Fibers, Skeletal; Muscle Proteins; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Oxidative Stress; Reactive Oxygen Species; Receptors, Adrenergic, beta-2; Sarcopenia; SKP Cullin F-Box Protein Ligases | 2021 |
Association of Sarcopenia and Gut Microbiota Composition in Older Patients with Advanced Chronic Kidney Disease, Investigation of the Interactions with Uremic Toxins, Inflammation and Oxidative Stress.
Topics: Aged; Bacteria; Gastrointestinal Microbiome; Humans; Indican; Inflammation; Interleukin-6; Malondialdehyde; Middle Aged; Oxidative Stress; Renal Dialysis; Renal Insufficiency, Chronic; Sarcopenia; Uremia; Uremic Toxins | 2021 |
Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction.
Topics: Animals; Antioxidants; Biomarkers; Cell Line; Chromatography, High Pressure Liquid; Creatinine; Cytokines; Disease Models, Animal; Humans; Indican; Inflammation Mediators; Male; Mice; Mitochondria; Myoblasts; Nitrogen; Phosphorylation; Proto-Oncogene Proteins c-akt; Renal Insufficiency, Chronic; Sarcopenia | 2017 |
The double-edged sword of endoplasmic reticulum stress in uremic sarcopenia through myogenesis perturbation.
Topics: Animals; Cell Differentiation; Cell Line; Endoplasmic Reticulum Stress; Indican; Mice; Muscle Development; Myoblasts; MyoD Protein; Proto-Oncogene Proteins c-akt; Sarcopenia; Unfolded Protein Response; Uremia | 2018 |
Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1.
Topics: Animals; Antioxidants; Cell Division; Cell Line; Cytokines; Disease Models, Animal; Gene Expression Regulation; Indican; Male; Mice; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Muscle Proteins; Muscle, Skeletal; Myoblasts; Myostatin; Nephrectomy; Organ Size; Organic Anion Transporters; Oxidative Stress; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Receptors, Aryl Hydrocarbon; Sarcopenia; SKP Cullin F-Box Protein Ligases; Superoxides; Uremia; Weight Loss | 2016 |
Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease.
Topics: Animals; Disease Models, Animal; Indican; Male; Mice; Muscle, Skeletal; Renal Insufficiency, Chronic; Sarcopenia; Uremia | 2016 |